Byron H. Arison

7.1k citations

191 papers · 5.5k indexed · h-index 40

Co-authors: Daniel F. Veber Karst Hoogsteen Nelson R. Trenner Ralph Hirschmann D. E. MCCLURE John J. Baldwin Karl Folkers G. ALBERS‐SCHOENBERG
Topics: Pharmacogenetics and Drug Metabolism (28 papers)Chemical Synthesis and Analysis (21 papers)Microbial Natural Products and Biosynthesis (17 papers)
Cited by: Pharmacology Biochemistry
Journals: Nature Science Journal of the American Chemical Society
Partner nations: United States Japan Sweden

In The Last Decade

Byron H. Arison

187 papers receiving 5.1k citations

Peers

Countries citing papers authored by Byron H. Arison

Since Specialization

Citations

This map shows the geographic impact of Byron H. Arison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byron H. Arison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byron H. Arison more than expected).

Fields of papers citing papers by Byron H. Arison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byron H. Arison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byron H. Arison. The network helps show where Byron H. Arison may publish in the future.

Co-authorship network of co-authors of Byron H. Arison

This figure shows the co-authorship network connecting the top 25 collaborators of Byron H. Arison. A scholar is included among the top collaborators of Byron H. Arison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byron H. Arison. Byron H. Arison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	METABOLISM AND DISPOSITION OF A POTENT AND SELECTIVE GABA-Aα2/3 RECEPTOR AGONIST IN HEALTHY MALE VOLUNTEERS 2006 ·Drug Metabolism and Disposition ·(unknown),S. Vickers,Donghui Cui,Raju Subramanian,Byron H. Arison,Nancy Agrawal,(unknown),(unknown),M. Gail Murphy,Kenneth C. Lasseter,Richard C. Simpson,José M. Vega,A. David Rodrigues	9
2	METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS 2003 ·Drug Metabolism and Disposition ·Donald Slaughter,Norihiro Takenaga,Ping Lü,(unknown),(unknown),Byron H. Arison,Donghui Cui,Rita A. Halpin,Leslie A. Geer,Kamlesh P. Vyas,Thomas A. Baillie	22
3	Structure–function relationships of rat liver CYP3A9 to its human liver orthologs: site-directed active site mutagenesis to a progesterone dihydroxylase 2002 ·Archives of Biochemistry and Biophysics ·Linlong Xue,Victor G. Zgoda,Byron H. Arison,Maria Almira Correia	19
4	Hemin-mediated restoration of allylisopropylacetamide-inactivated CYP2B1: a role for glutathione and GRP94 in the heme–protein assembly 2002 ·Archives of Biochemistry and Biophysics ·Victor G. Zgoda,Byron H. Arison,Souren Mkrtchian,Magnus Ingelman‐Sundberg,Maria Almira Correia	6
5	Structure-function studies on the cyclic peptide MT-II, lactam derivative of α-melanotropin 1999 ·Peptides ·Maria A. Bednarek,Maria V. Silva,Byron H. Arison,Tanya MacNeil,Rubana N. Kalyani,(unknown),David H. Weinberg	62
6	In Vitro and In Vivo Studies on the Metabolism of Tirofiban 1999 ·Drug Metabolism and Disposition ·S. Vickers,Anthony D. Theoharides,Byron H. Arison,Suresh K. Balani,Dan Cui,C A Duncan,Joan D. Ellis,Lynn M. Gorham,(unknown),Thomayant Prueksaritanont,Harri G. Ramjit,Donald E. Slaughter,Kamlesh P. Vyas	32
7	A Tethered Porphyrin Dimer with π Overlap of a Single Pyrrole Ring 1998 ·Angewandte Chemie International Edition ·Spencer Knapp,(unknown),Thomas J. Emge,Byron H. Arison,J.A. Potenza,Harvey J. Schugar	38
8	Farnesol-derived Dicarboxylic Acids in the Urine of Animals Treated with Zaragozic Acid A or with Farnesol 1997 ·Journal of Biological Chemistry ·Richard G. Bostedor,John D. Karkas,Byron H. Arison,Vinay S. Bansal,Sanskruti Vaidya,John I. Germershausen,Marc M. Kurtz,James D. Bergstrom	56
9	Microbial transformation ofN-heptyl physostigmine, a semisynthetic alkaloid inhibitor of cholinesterase 1995 ·Journal of Industrial Microbiology & Biotechnology ·(unknown),Rebecca B. White,Byron H. Arison,(unknown),Michael S. Schwartz,Hsien C. Cheng,Richard L. Monaghan,(unknown)	4
10	Microbial transformations of immunosuppressive compounds. IV. Hydroxylation and hemiketal formation of ascomycin(immunomycin) by Streptomyces sp. MA6970(ATCC No.55281). 1994 ·The Journal of Antibiotics ·(unknown),(unknown),Richard White,Gabe Dezeny,(unknown),Byron H. Arison,T. R. BEATTIE,(unknown),Francis J. Dumont,Richard L. Monaghan	2
11	Microbial conversion of avermectins by Saccharopolyspora erythrea: Hydroxylation at C28. 1993 ·The Journal of Antibiotics ·Marvin Schulman,Patrick Doherty,Deborah L. Zink,Byron H. Arison	9
12	Microbial transformation of immunosuppressive compounds. II. Specific desmethylation of 13-methoxy group of FK 506 and FR 900520 by Actinomycete sp. ATCC 53828. 1992 ·The Journal of Antibiotics ·(unknown),Byron H. Arison,Linda S. Wicker,Edward Inamine	9
13	[Neolignans from Piper polysyphorum C.DC]. 1991 ·PubMed ·(unknown),(unknown),(unknown),(unknown),Byron H. Arison,S B Hwang	13
14	Metabolism of the platelet-activating factor antagonist (±)-trans-2-(3′-methoxy-5′-methylsulphonyl-4′-propoxyphenyl)-5-(3″, 4″,5″-trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys 1991 ·Xenobiotica ·Kate Thomson,Ming‐Wen Chang,Robert L. Bugianesi,Mitree M. Ponpipom,Byron H. Arison,H. Hücker,(unknown),(unknown),John C. Chabala	2
15	HIV-1 protease inhibitory activity of L-694,746, a novel metabolite of L-689,502 1991 ·Biochemical and Biophysical Research Communications ·Russell B. Lingham,Byron H. Arison,(unknown),Amy Hsu,(unknown),Wayne J. Thompson,George M Garrity,(unknown),Frederick W. Hartner,Paul L. Darke,Suresh K. Balani,Steven M. Pitzenberger,(unknown),Harri G. Ramjit,Edward Inamine,L. Treiber	5
16	Identification and possible role of d-mannitol and 2-O-methyl-chiroinositol (quebrachitol) in Eimeria tenella 1988 ·Molecular and Biochemical Parasitology ·Dennis M. Schmatz,Byron H. Arison,(unknown),Jerrold M. Liesch,Mark S. Turner	10
17	Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys. 1983 ·Drug Metabolism and Disposition ·H. Hücker,(unknown),(unknown),Byron H. Arison,Anthony G. Zacchei	67
18	PHYSIOLOGICAL DISPOSITION AND METABOLISM OF CYCLOBENZAPRINE IN THE RAT, DOG, RHESUS MONKEY, AND MAN 1978 ·Drug Metabolism and Disposition ·H. Hücker,(unknown),(unknown),(unknown),Anthony G. Zacchei,Byron H. Arison	44
19	EPOXIDE METABOLITES OF PROTRIPTYLINE IN RAT URINE 1975 ·Drug Metabolism and Disposition ·H. Hücker,(unknown),J.L. Demetriades,Byron H. Arison,Anthony G. Zacchei	9
20	N-GLUCOSIDE FORMATION AS A DETOXIFICATION MECHANISM IN MAMMALS 1974 ·Journal of Pharmacology and Experimental Therapeutics ·D E Duggan,J. J. Baldwin,Byron H. Arison,Ryan E. Rhodes	30

About Byron H. Arison

Byron H. Arison is a scholar working on Pharmacology, Biochemistry and Organic Chemistry, having authored 191 papers that have together received 5.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (28 papers), Chemical Synthesis and Analysis (21 papers) and Microbial Natural Products and Biosynthesis (17 papers). The work is most often cited by research in Pharmacology (677 citations), Pharmacology (880 citations) and Biochemistry (368 citations). Byron H. Arison has collaborated with scholars based in United States, Japan and Sweden. Frequent co-authors include Daniel F. Veber, Karst Hoogsteen, Nelson R. Trenner, Ralph Hirschmann, D. E. MCCLURE, John J. Baldwin, Karl Folkers, G. ALBERS‐SCHOENBERG, Jack L. Smith and Kamlesh P. Vyas. Their work appears in journals such as Nature, Science and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact